From Days to Hours: Reporting Clinically Actionable Variants from Whole Genome Sequencing

被引:3
|
作者
Middha, Sumit [1 ]
Baheti, Saurabh [1 ]
Hart, Steven N. [1 ]
Kocher, Jean-Pierre A. [1 ]
机构
[1] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA
来源
PLOS ONE | 2014年 / 9卷 / 02期
关键词
BURROWS-WHEELER TRANSFORM; READ ALIGNMENT;
D O I
10.1371/journal.pone.0086803
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
As the cost of whole genome sequencing (WGS) decreases, clinical laboratories will be looking at broadly adopting this technology to screen for variants of clinical significance. To fully leverage this technology in a clinical setting, results need to be reported quickly, as the turnaround rate could potentially impact patient care. The latest sequencers can sequence a whole human genome in about 24 hours. However, depending on the computing infrastructure available, the processing of data can take several days, with the majority of computing time devoted to aligning reads to genomics regions that are to date not clinically interpretable. In an attempt to accelerate the reporting of clinically actionable variants, we have investigated the utility of a multi-step alignment algorithm focused on aligning reads and calling variants in genomic regions of clinical relevance prior to processing the remaining reads on the whole genome. This iterative workflow significantly accelerates the reporting of clinically actionable variants with no loss of accuracy when compared to genotypes obtained with the OMNI SNP platform or to variants detected with a standard workflow that combines Novoalign and GATK.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Identification of clinically actionable variants from genome sequencing of families with congenital heart disease
    Alankarage, Dimuthu
    Ip, Eddie
    Szot, Justin O.
    Munro, Jacob
    Blue, Gillian M.
    Harrison, Katrina
    Cuny, Hartmut
    Enriquez, Annabelle
    Troup, Michael
    Humphreys, David T.
    Wilson, Meredith
    Harvey, Richard P.
    Sholler, Gary F.
    Graham, Robert M.
    Ho, Joshua W. K.
    Kirk, Edwin P.
    Pachter, Nicholas
    Chapman, Gavin
    Winlaw, David S.
    Giannoulatou, Eleni
    Dunwoodie, Sally L.
    [J]. GENETICS IN MEDICINE, 2019, 21 (05) : 1111 - 1120
  • [2] Identification of clinically actionable secondary genetic variants from whole-genome sequencing in a large-scale Chinese population
    Cong, Pei-Kuan
    Khederzadeh, Saber
    Yuan, Cheng-Da
    Ma, Rui-Jie
    Zhang, Yi-Yao
    Liu, Jun-Quan
    Yu, Shi-Hui
    Xu, Lin
    Gao, Jian-Hua
    Pan, Hong-Xu
    Li, Jin-Chen
    Xie, Shu-Yang
    Liu, Ke-Qi
    Tang, Bei-Sha
    Zheng, Hou-Feng
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (05):
  • [3] Identification and Interpretation of Clinically Relevant Somatic Variants from Whole-Genome Sequencing Data
    Maqbool, Khurram
    Foroughi-Asl, Hassan Hassan
    Jeggari, Ashwini Ashwini
    Ivanchuk, Vadym
    Eisfeldt, Jesper
    Renevey, Annick
    Elhami, Keyvan
    Rasi, Chiara
    Nilsson, Daniel
    Heinaniemi, Merja
    Lohi, Olli
    Wirta, Valtteri
    [J]. BLOOD, 2022, 140 : 13003 - 13004
  • [4] Incidental and clinically actionable genetic variants in 1005 whole exomes and genomes from Qatar
    Jain, Abhinav
    Gandhi, Shrey
    Koshy, Remya
    Scaria, Vinod
    [J]. MOLECULAR GENETICS AND GENOMICS, 2018, 293 (04) : 919 - 929
  • [5] Incidental and clinically actionable genetic variants in 1005 whole exomes and genomes from Qatar
    Abhinav Jain
    Shrey Gandhi
    Remya Koshy
    Vinod Scaria
    [J]. Molecular Genetics and Genomics, 2018, 293 : 919 - 929
  • [6] Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing
    Schuh, Anna
    Dreau, Helene
    Knight, Samantha J. L.
    Ridout, Kate
    Mizani, Tuba
    Vavoulis, Dimitris
    Colling, Richard
    Antoniou, Pavlos
    Kvikstad, Erika M.
    Pentony, Melissa M.
    Hamblin, Angela
    Protheroe, Andrew
    Parton, Marina
    Shah, Ketan A.
    Orosz, Zsolt
    Athanasou, Nick
    Hassan, Bass
    Flanagan, Adrienne M.
    Ahmed, Ahmed
    Winter, Stuart
    Harris, Adrian
    Tomlinson, Ian
    Popitsch, Niko
    Church, David
    Taylor, Jenny C.
    [J]. COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2018, 4 (02):
  • [7] Detection of clinically relevant genetic variants in nanophthalmos by whole genome sequencing
    Fan, Zhigang
    Guo, Congcong
    Zhao, Zhenni
    Chen, Denghui
    He, Shuxiang
    Sun, Nannan
    Li, Zhongwen
    Liu, Jiafan
    Zhang, Dandan
    Zhang, Jiamin
    Li, Jianlong
    Zhang, Miao
    Yu, Shihui
    Zhao, Weiwei
    Liu, Jingxing
    Zhang, Xiaoling
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [8] Actionable secondary findings from whole-genome sequencing of 954 East Asians
    Clara Sze-man Tang
    Saloni Dattani
    Man-ting So
    Stacey S. Cherny
    Paul K. H. Tam
    Pak C. Sham
    Maria-Mercè Garcia-Barcelo
    [J]. Human Genetics, 2018, 137 : 31 - 37
  • [9] Actionable secondary findings from whole-genome sequencing of 954 East Asians
    Tang, Clara Sze-man
    Dattani, Saloni
    So, Man-ting
    Cherny, Stacey S.
    Tam, Paul K. H.
    Sham, Pak C.
    Garcia-Barcelo, Maria-Merce
    [J]. HUMAN GENETICS, 2018, 137 (01) : 31 - 37
  • [10] Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review
    Douglas, Michael P.
    Ladabaum, Uri
    Pletcher, Mark J.
    Marshall, Deborah A.
    Phillips, Kathryn A.
    [J]. GENETICS IN MEDICINE, 2016, 18 (02) : 111 - 116